Angiex, Inc. filed an amended Form D with the Securities and Exchange Commission on 2025-08-14.
Angiex, Inc. filed an amended Form D notice of an exempt securities offering with the SEC on August 14, 2025. The filing reports $21.99M sold. Its industry group is Biotechnology. It names Paul Jaminet (Executive Officer, Director), Amal Amin (Director), Jason Camm (Director) (SEC Form D/A, August 14, 2025).
Is this your company?
Sell to companies like Angiex, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-14 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Angiex, Inc.
Free to see. No signup.
More on the people and the money behind Angiex, Inc., from the filings we hold.
Paulson Investment Company, LLC received sales compensation on this raise and on 6 other raises we hold, nearest in date first:
Biotechnology raises by companies based in Massachusetts, filed in August 2025, largest first.
Get an email when Angiex, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Angiex, Inc. raises, hires or launches. No email unless you switch it on.
Watch Angiex, Inc. →Get the full cited report on Angiex, Inc.
What the filing shows about Angiex, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Angiex, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Angiex, Inc.'s address as 150 Cambridge Park Drive, 5th Floor, Cambridge, MA 02140.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for Angiex, Inc. →
Amended on 2025-09-26: the offering size changed from $20,284,497 to $28,409,510; the amount sold changed from $10,980,030 to $21,991,695; the number of investors changed from 57 to 137; finders' fees changed from $1,624,228 to $2,432,708. Figures on this page are from the amendment. Amended filing · Original filing
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Angiex, Inc. is a registered filer with the SEC (CIK 1710380) and has filed since 2025-08-14. 2 filings are on record, the latest on 2025-09-26.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Angiex, Inc.'s Form D of 2025-08-14 names Paul Jaminet, Amal Amin, Jason Camm and 6 more as its officers, directors or promoters.
Its new offerings report $10.98M sold across 1 offering, as its own filings state.
A hollow marker is an amendment (Form D/A); a solid one is an original Form D. The larger marker is the filing this page is about.
Trailing twelve months. 769 filings in Biotechnology, totalled by week.
Paul Jaminet is named as Executive Officer and Director on the Form D that Angiex, Inc. filed with the SEC on 14 August 2025, one of 9 people that filing names.
Amal Amin is named as Director on the Form D that Angiex, Inc. filed with the SEC on 14 August 2025, one of 9 people that filing names.
Jason Camm is named as Director on the Form D that Angiex, Inc. filed with the SEC on 14 August 2025, one of 9 people that filing names.
Haijing Guo is named as Director on the Form D that Angiex, Inc. filed with the SEC on 14 August 2025, one of 9 people that filing names.
Fabian Hansen is named as Director on the Form D that Angiex, Inc. filed with the SEC on 14 August 2025, one of 9 people that filing names.
Tina Neel is named as Director on the Form D that Angiex, Inc. filed with the SEC on 14 August 2025, one of 9 people that filing names.
Jonathan Adams is named as Director on the Form D that Angiex, Inc. filed with the SEC on 14 August 2025, one of 9 people that filing names.
Iain Dukes is named as Director on the Form D that Angiex, Inc. filed with the SEC on 14 August 2025, one of 9 people that filing names.
Errik Anderson is named as Director on the Form D that Angiex, Inc. filed with the SEC on 14 August 2025, one of 9 people that filing names.
9 people named on the filing — 1 holding an executive role and 8 as directors only.
Named as of the 2025-08-14 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Angiex, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Angiex, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Angiex, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Angiex, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Angiex, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Angiex, Inc.. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/angiex-inc-form-d-25000001